SYDNEY, AUSTRALIA: CRO Novotech said that it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an affiliate of an international healthcare company, Sonic Healthcare.
Novotech is a multi-award winning, leading regional contract research organisation (CRO) in Australia.
Sonic Clinical Trials is also a registered Research Service Provider (RSP) with AusIndustry, a division of the Australian Government’s Department of Industry, Innovation and Science.
Through this unique partnership, Novotech clients will be able to select from a wide menu of assays or biomarkers, access a trial-specific kit assembly service and use a single clinical trial-dedicated laboratory with a global reach, for priority processing of clinical trial samples.
“Novotech has always focused on offering flexible and cost effective clinical trial solutions. Through our partnership with Sonic Clinical Trials, our clients will experience a seamless integration of laboratory services and clinical trial data management by Novotech. From the start to finish, our clients are supported by a team of dedicated project managers,” said Dr John Moller, CEO of Novotech.
© Chemical Today News
Read More: Novotech signs central lab services agreement with Sonic
No comments:
Post a Comment